Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Volume 31, Number 11—November 2025

Research

Monkeypox Virus Partial-Genome Amplicon Sequencing for Improvement of Genomic Surveillance during Mpox Outbreaks

Jiusheng Deng, Daisy McGrath, Kimberly Wilkins, Luis A. Haddock, Whitni Davidson, Demi B. Rabeneck, Joseph Madden, Vaughn Wicker, Adrienne Amuri-Aziza, Tony Wawina-Bokalanga, Placide Mbala-Kingebeni, Christina L. Hutson, Yu Li, and Crystal GiganteComments to Author 
Author affiliation: Chenega Enterprise Systems and Solutions, LLC, Chesapeake, Virginia, USA (J. Deng); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (J. Deng, D. McGrath, K. Wilkins, L.A. Haddock, W. Davidson, D.B. Rabeneck, J. Madden, V. Wicker, C.L. Hutson, Y. Li, C. Gigante); University of Kinshasa, Kinshasa, Democratic Republic of the Congo (A. Amuri-Aziza, T. Wawina-Bokalanga, P. Mbala-Kingebeni)

Main Article

Table 1

Characteristics of MPXV specimens with Ct <30 and amplicon sequencing read depths over the 10-kb and 15-kb genomic region of MPXV for study of partial-genome amplicon sequencing for improvement of genomic surveillance during mpox outbreaks*

Specimen no. Source/sample type Country/year DNA concentration, ng/μL Ct 10-kb 15-kb
1 Back/lesion USA/2024 4.7 19.8 1,279 554
2 Swab drag USA/2024 5.6 22.7 840 408
3 Chest lesion USA/2024 1.2 21.0 3,800 465
4 Lesion USA/2024 4.3 22.6 1,455 324
5 Back/lesion USA/2024 1.0 21.1 3,046 449
6 Leg/skin swab USA/2024 8.4 20.1 1,625 328
7 Skin swab USA/2024 1.0 22.0 1,417 487
8 Eye/swab drag USA/2024 4.0 21.2 1,019 345
9 Penis/swab USA/2024 10.7 19.2 1,097 464
10 Penis/skin swab USA/2024 1.4 21.7 1,750 584
11 Penis/skin swab USA/2024 9.3 19.9 2,760 479
12 Chest/skin swab USA/2024 9.1 21.9 950 116
13 Back/skin swab USA/2024 4.6 19.6 2,365 557
14 Hand/skin swab USA/2024 22.0 20.5 1,870 461
15 Perianal/swab USA/2024 2.9 21.3 1,259 432
16 Penis/skin swab USA/2024 2.1 19.6 2,363 281
17 Perianal/swab USA/2024 23.0 23.3 2,764 264
18 Penis/skin swab USA/2024 1.0 20.8 1,673 652
19 Penis/lesion USA/2024 10.9 21.5 932 241
20 Lesion USA/2024 2.5 23.8 3,095 272
21 Crusts DRC/2017 2.3 16.0 3,612 329
22 Vesicles DRC/2017 1.9 16.0 1,819 1,231
23 Vesicles DRC/2016 8.1 15.2 1,361 1,653
24 Vesicles DRC/2017 16.0 16.7 1,421 1,607
25 Vesicles DRC/2017 9.1 15.6 1,778 2,169
26 Crusts DRC/2016 89.0 13.0 142 1,469
27 Vesicles DRC/2017 62.0 18.0 797 1,056
28 Vesicles DRC/2017 30.0 17.0 212 670
29 Vesicles DRC/2017 28.0 22.3 1,180 762
30 Vesicles DRC/2016 20.0 20.7 783 698
31 Swab DRC/2024 0.8 22.6 2,022 1,520
32 Swab DRC/2024 0.2 25.2 2,300 1,835
33 Swab DRC/2024 6.0 17.7 1,856 1,339
34 Swab DRC/2024 9.0 17.8 1,147 895
35 Swab DRC/2024 0.2 25.1 1,907 1,532
36 Swab DRC/2024 4.9 19.0 1,718 1,254

*Total DNA was extracted from MPXV specimens (n = 36) from different body sources of patients in USA in 2024 (nos. 1–20) or in DRC during 2016–2024 (nos. 21–36). DNA concentrations (ng/µL), MPXV Ct values, and read depths over the 2 genomic regions of MPXV genomes (10-kb and 15-kb) derived from amplicon sequencing on DNA samples included. Ct, cycle threshold; DRC, Democratic Republic of the Congo; MPXV, monkeypox virus; USA, United States.

Main Article

Page created: November 18, 2025
Page updated: December 10, 2025
Page reviewed: December 10, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external